In 1841, the extraction of hematoporphyrin from dried blood by removing iron marked the
birth of the photosensitizer. The last twenty years has witnessed extensive research in the …

Photoactivated therapeutic strategies (photothermal therapy and photodynamic therapy),
due to the adjusted therapeutic area, time and light dosage, have prevailed for the fight …

Traditional cancer therapeutics have been criticized due to various adverse effects and
insufficient damage to targeted tumors. The breakthrough of nanoparticles provides a novel …

Recent advances in drug delivery technologies utilizing a variety of carriers have resulted in
a paradigm shift in the current approach to diagnosis and therapy. Mesoporous silica …

The increasing cancer morbidity and mortality requires the development of high-efficiency
and low-toxicity anticancer approaches. In recent years, photodynamic therapy (PDT) has …

The invention of silica-based bioactive glass in the late 1960s has sparked significant
interest in exploring a wide range of silicon-containing biomaterials from the macroscale to …

This review article is based on specifically targeted nanoparticles that have been used in the
treatment of melanoma. According to the Skin Cancer Foundation, within 2017 an estimated …

Verteporfin (VP) has long been clinically used to treat age-related macular degeneration
(AMD) through photodynamic therapy (PDT). Recent studies have reported a significant anti …

Malignant melanoma poses a significant global health burden. It is the most aggressive and
lethal form of skin cancer, attributed to various risk factors such as UV radiation exposure …

Advanced ovarian cancer is the most lethal gynecological cancer, with a high rate of
chemoresistance and relapse. Photodynamic therapy offers new prospects for ovarian …